Načítá se...
The Use of Telmisartan and the Incidence of Cancer
BACKGROUND: A meta-analysis reported an 8% increased risk of cancer with the use of angiotensin receptor blockers (ARBs), but subsequent meta-analyses and observational studies did not confirm this risk. However, telmisartan comprised 85% of the data in the original meta-analysis. Thus, the objectiv...
Uloženo v:
| Vydáno v: | Am J Hypertens |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5863774/ https://ncbi.nlm.nih.gov/pubmed/27557862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajh/hpw095 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|